Halcet Infusion, containing Paracetamol at a concentration of 1% w/v, is an intravenous formulation indicated for the management of mild to moderate pain and the reduction of fever when oral administration is not feasible. Paracetamol, a widely used analgesic and antipyretic agent, exerts its effect primarily through central inhibition of prostaglandin synthesis, thereby modulating pain perception and thermoregulation. Halcet Infusion is particularly beneficial in clinical settings requiring rapid onset of action, such as postoperative pain, severe febrile conditions, or in patients with impaired gastrointestinal function. The intravenous route ensures prompt bioavailability and precise dosing, making it suitable for use in hospitals and emergency care. The formulation is typically administered under medical supervision, with dosage adjusted according to patient weight, age, and clinical condition to minimize the risk of hepatotoxicity associated with overdose. Caution is advised in patients with pre-existing liver impairment or chronic alcohol use. Halcet Infusion should be used as part of a comprehensive pain management plan, and healthcare professionals should monitor liver function during prolonged therapy. It is contraindicated in patients with hypersensitivity to paracetamol or any excipients in the formulation.